KOSPI · Healthcare · ₩1T
₩111,900-1.15%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 10.7% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기는 나보타 해외 확장이 성장을 이끌었어요.”
In the company's words · 2026 2분기 filing